A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing

Genome Research

Volumn 22, Issue 3, 2012, Pages 436-445

  Ju, Young Seok ^a,b   Lee, Won Chul ^a   Shin, Jong Yeon ^a,c   Lee, Seungbok ^a   Bleazard, Thomas ^a   Won, Jae Kyung ^d   Kim, Young Tae ^e,f   Kim, Jong Il ^a,c,f   Kang, Jin Hyoung ^g   Seo, Jeong Sun ^a,b,c,f  

^a Seoul National University   (South Korea)

^b Macrogen Inc   (South Korea)

^c Psoma Therapeutics Inc   (South Korea)

^d Seoul National University Cancer Hospital   (South Korea)

^e Seoul National University Hospital   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

^g The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; EML4 ALK FUSION PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; KIF5B RET FUSION PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CELL TRANSFORMATION; CHROMOSOME 10P; CONTROLLED STUDY; FUSION GENE; GENE FUSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; ONCOGENE K RAS; ONCOGENE RET; PERICENTRIC CHROMOSOME INVERSION; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; RNA SEQUENCE;

ADENOCARCINOMA; ADULT; ALTERNATIVE SPLICING; BASE SEQUENCE; CHROMOSOME BREAKPOINTS; CHROMOSOMES, HUMAN, PAIR 10; EXONS; GENE ORDER; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KINESIN; LUNG NEOPLASMS; MALE; MODELS, MOLECULAR; ONCOGENE PROTEINS, FUSION; PROTEIN CONFORMATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-RET; TRANSCRIPTOME; TRANSLOCATION, GENETIC;

EID: 84863230117     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.133645.111     Document Type: Article

References (42)

1. Alberti L, Carniti C, Miranda C, Roccato E, Pierotti MA. 2003. RET and NTRK1 proto-oncogenes in human diseases. J Cell Physiol 195: 168-186. (Pubitemid 36384291)
2. Daire V, Pous C. 2011. Kinesins and protein kinases: key players in the regulation of microtubule dynamics and organization. Arch Biochem Biophys 510: 83-92.
3. Dawson DM, Lawrence EG, MacLennan GT, Amini SB, Kung HJ, Robinson D, Resnick MI, Kursh ED, Pretlow TP, Pretlow TG. 1998. Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer. J Natl Cancer Inst 90: 519-523. (Pubitemid 28182545)
4. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, et al. 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381: 789-793. (Pubitemid 26243119)
5. Durbin R, Altshuler D, Abecasis G, Bentley D, Chakravarti A, Clark A, Collins FS, De La Vaga F, Donnelly P, Egholm M, et al. 2010. A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
6. Eberhard DA, Johnson BE, Amler LC, Goddard AD, Heldens SL, Herbst RS, Ince WL, Janne PA, Januario T, Johnson DH, et al. 2005. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J ClinOncol 23: 5900-5909.
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
8. Harris T. 2010. Does large scale DNA sequencing of patient and tumor DNA yet provide clinically actionable information? Discov Med 10: 144-150.
9. Hastings PJ, Ira G, Lupski JR. 2009. A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5: e1000327. doi: 10.1371/journal.pgen.1000327.
10. Ju YS, Kim JI, Kim S, Hong D, Park H, Shin JY, Lee S, Lee WC, Yu SB, Park SS, et al. 2011. Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals. Nat Genet 43: 745-752.
11. Kawai K, Iwashita T, Murakami H, Hiraiwa N, Yoshiki A, Kusakabe M, Ono K, Iida K, Nakayama A, Takahashi M. 2000. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation. Cancer Res 60: 5254-5260.
12. Kee Y, D'Andrea AD. 2010. Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev 24: 1680-1694.
13. Kelley LA, Sternberg MJ. 2009. Protein structure prediction on the web: a case study using the Phyre server. Nat Protoc 4: 363-371.
14. Kim JI, Ju YS, Park H, Kim S, Lee S, Yi JH, Mudge J, Miller NA, Hong D, Bell CJ, et al. 2009. A highly annotated whole-genome sequence of a Korean individual. Nature 460: 1011-1015.
15. Kumar P, Henikoff S, Ng PC. 2009. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4: 1073-1081.
16. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, Ou SH, Dezube BJ, Janne PA, Costa DB, et al. 2010. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363: 1693-1703.
17. Lee YJ, Kim JH, Kim SK, Ha SJ, Mok TS, Mitsudomi T, Cho BC. 2011. Lung cancer in never smokers: change of amindset in the molecular era. Lung Cancer 72: 9-15.
18. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, et al. 2004. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139. (Pubitemid 38637993)
19. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628. (Pubitemid 351911867)
20. Nacu S, YuanW, Kan Z, Bhatt D, Rivers CS, Stinson J, Peters BA, Modrusan Z, Jung K, Seshagiri S, et al. 2011. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples. BMC Med Genomics 4: 11. doi: 10.1186/1755-8794-4-11.
21. Nambiar M, Goldsmith G, Moorthy BT, Lieber MR, Joshi MV, Choudhary B, Hosur RV, Raghavan SC. 2011. Formation of a G-quadruplex at the BCL2 major breakpoint region of the t(14;18) translocation in follicular lymphoma. Nucleic Acids Res 39: 936-948.
22. Ohshima Y, Yajima I, Takeda K, Iida M, Kumasaka M, Matsumoto Y, Kato M. 2010. c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines. PLoS ONE 5: e10279. doi: 10.1371/journal.pone.0010279.
23. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, et al. 2004. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500. (Pubitemid 38720929)
24. Pao W, Girard N. 2011. New driver mutations in non-small-cell lung cancer. Lancet Oncol 12: 175-180.
25. Portella G, Salvatore D, Botti G, Cerrato A, Zhang L, Mineo A, Chiappetta G, Santelli G, Pozzi L, Vecchio G, et al. 1996. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. Oncogene 13: 2021-2026. (Pubitemid 26397463)
26. Riely GJ, Kris MG, Rosenbaum D, Marks J, Li A, Chitale DA, Nafa K, Riedel ER, Hsu M, Pao W, et al. 2008. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin Cancer Res 14: 5731-5734.
27. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH. 2002. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98. (Pubitemid 34438899)
28. Score J, Curtis C, Waghorn K, Stalder M, Jotterand M, Grand FH, Cross NC. 2006. Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia. Leukemia 20: 827-832.
29. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, et al. 2009. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461: 809-813.
30. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, et al. 2007. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448: 561-566. (Pubitemid 47206930)
31. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, et al. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci 99: 4465-4470. (Pubitemid 34286008)
32. Subramanian J, Govindan R. 2007. Lung cancer in never smokers: a review. J Clin Oncol 25: 561-570. (Pubitemid 350002964)
33. Takahashi M, Ritz J, Cooper GM. 1985. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42: 581-588. (Pubitemid 16091150)
34. Takeuchi K, Choi YL, Togashi Y, Soda M, Hatano S, Inamura K, Takada S, Ueno T, Yamashita Y, Satoh Y, et al. 2009. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer. Clin Cancer Res 15: 3143-3149.
35. Tao J, Deng NT, Ramnarayanan K, Huang B, Oh HK, Leong SH, Lim SS, Tan IB, Ooi CH, Wu J et al. 2011. CD44-SLC1A2 gene fusions in gastric cancer. Sci Transl Med 3: 77ra30. doi: 10.1126/scitranslmed.3001423.
36. Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, Hsu AA, Eng P, Koong HN, Thirugnanam A, et al. 2006. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 24: 2245-2251. (Pubitemid 46630653)
37. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, et al. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648. (Pubitemid 41528150)
38. Welch JS, Westervelt P, Ding L, Larson DE, Klco JM, Kulkarni S, Wallis J, Chen K, Payton JE, Fulton RS, et al. 2011. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA 305: 1577-1584.
39. Wong DW, Leung EL, So KK, Tam IY, Sihoe AD, Cheng LC, Ho KK, Au JS, Chung LP, PikWong M. 2009. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 115: 1723-1733.
40. Wu TD, Nacu S. 2010. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 26: 873-881.
41. Zeng Q, Cheng Y, Zhu Q, Yu Z, Wu X, Huang K, Zhou M, Han S, Zhang Q. 2008. The relationship between overexpression of glial cell-derived neurotrophic factor and its RET receptor with progression and prognosis of human pancreatic cancer. J Int Med Res 36: 656-664.
42. Zhang F, Carvalho CM, Lupski JR. 2009. Complex human chromosomal and genomic rearrangements. Trends Genet 25: 298-307.